Skip to content

Korea Equity Lens

  • About
  • IR Room
  • Research
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • EV & Battery
    • Automotive
    • Energy
    • Robotics
    • Shipbuilding
  • Toggle search form
  • [Research] Alteogen (196170) – Daishin Securities | Keytruda Qlex Commercial Milestones · RNA Modality Expansion · Platform Re-rating / 2026-08-10 Research
  • [IR] Samsung Electro-Mechanics (009150) – Q2 2026 Earnings Presentation / 2026-07-30 IR Room
  • [Research] SK hynix (000660 / SKHY) – Hanwha | LTA · HBM · Valuation Re-rating / 2026-06-22 Research
  • [Research] ABL Bio (298380) – Kyobo Securities | ABL001 Clinical Data · Market Overreaction · Grabody-B Potential / 2026-04-29 Research
  • [Research] SK hynix (000660 / SKHY) – Kiwoom | Legacy Memory Pricing · Earnings Upgrades · Volume Growth / 2026-03-03 Research
  • [Research] Samsung SDI (006400) – Shinhan Securities | US ESS Demand Surges · BBU Growth · 4Q26 Turnaround / 2026-04-29 Research
  • [Research] Hanwha Ocean (042660) – SK Securities | Merchant Margin Surprise · Cost & Incentive Factors · Earnings Volatility / 2026-07-28 Research
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | Memory Pricing · Supply Deficit · Valuation Appeal / 2026-03-04 Research

[Research] Samsung SDI (006400) – Hanwha Investment & Securities | Sequential Segment Recovery · Order Pipeline Visibility · Form Factor Diversification / 2026-04-29

Posted on April 29, 2026August 22, 2026 By ksb220805@gmail.com

Brokerage : Hanwha Investment & Securities

Analyst : Yong-wook Lee

Investment Rating : BUY (Maintained)

Target Price : KRW 820,000 (Raised)

Core Momentum : Embarking on a sequential quarterly turnaround across all segments starting in 2026, while securing medium- to long-term earnings visibility toward 2028 and beyond via major new order wins from Hyundai/Kia, Mercedes-Benz, and BMW.

📊 1. [Valuation & Key Financial Metrics]

  • Investment Rating & Target Price: BUY (Maintained), Target Price KRW 820,000 (Raised)
  • Market Data (As of 2026-04-28): Current Price KRW 680,000 (Upside Potential 20.6%), Market Cap KRW 54.80 Trillion, Shares Outstanding 80,586 Thousand, Foreign Ownership 25.7%
  • Key Financial Forecasts (2025 → 2026E → 2027E):
    • Revenue: KRW 13.27 Trillion → KRW 15.49 Trillion → KRW 19.96 Trillion
    • Operating Profit: KRW -1.72 Trillion → KRW -54.0 Billion (Loss Narrowed) → KRW 1.74 Trillion (Turnaround)
    • EBITDA: KRW 381.0 Billion → KRW 2.39 Trillion → KRW 4.22 Trillion
    • Net Profit (Controlling): KRW -649.0 Billion → KRW 327.0 Billion (Turnaround) → KRW 1.55 Trillion
    • EPS: KRW -8,059 → KRW 4,232 (Turnaround) → KRW 20,115
    • ROE: -3.2% → 1.5% → 6.9%
    • PER / PBR: -84.4x / 2.6x → 160.7x / 2.6x → 33.8x / 2.4x
    • EV/EBITDA: 169.2x → 27.4x → 15.2x
    • Net Debt: KRW 9.06 Trillion → KRW 10.26 Trillion → KRW 8.99 Trillion

🚀 2. [Market Opportunities & Business Outlook]

  • 1Q26 Earnings Review: Revenue reached KRW 3.6 Trillion and Operating Loss stood at KRW -156.6 Billion (Loss of KRW -236.1 Billion excluding AMPC), beating consensus (Operating Loss KRW -257.6 Billion). Driven by client compensation, robust small battery shipments (tabless, BBU, power tools), partial utilization recovery at the Hungarian plant, and initial European shipments from the STLA JV recognizing AMPC.
  • 2Q26 Earnings Outlook: Projected Revenue of KRW 3.7 Trillion and Operating Loss of KRW -73.3 Billion (Loss of KRW -151.5 Billion excluding AMPC). Despite base effects from 1Q compensation, quarterly recovery remains distinct backed by volume shipments for the Kia EV2 and the scheduled launch of the Hyundai Ioniq 3 in 2H26. ESS is set to rebound on US sales and domestic project ramp-ups, while small batteries and electronic materials maintain positive momentum.
  • Medium- to Long-Term Order Momentum & Visibility:
    • Customer Diversification: Overcoming past client churn concerns by commencing prismatic EV supply to Hyundai/Kia in 2026, followed by planned shipments to Mercedes-Benz (prismatic) and BMW (46-series) by 2028.
    • North American LFP Visibility: The STLA JV LFP lines scheduled for mass production in 2027 are believed to have secured most of the expected volumes for the initial 2–3 years, with additional European project potential upon further IAA formalization.

📝 Editor’s Comment (Perspective)

The analyst views Samsung SDI as a battery manufacturer moving past historical client concentration risks and embarking on a multi-year recovery phase, reinforced by new platform wins across global OEMs (Hyundai/Kia, Mercedes-Benz, BMW) and a diversified product portfolio (prismatic, 46-series, LFP). This perspective highlights the initiation of a sequential, company-wide operational recovery in 2026 and the strengthening of long-term contract visibility toward 2028, rather than focusing on quarterly margin swings caused by non-recurring client compensation.

To evaluate the ongoing validity of this investment thesis, key monitoring variables include the sequential recovery of automotive battery revenue driven by volume rollouts for the Kia EV2 and Hyundai Ioniq 3, commercial readiness of the expected volume pipeline at the STLA JV LFP line ahead of 2027 production, and concrete execution timelines for upcoming supply contracts with Mercedes-Benz (prismatic) and BMW (46-series). These developments can be verified through upcoming quarterly earnings announcements, official IR releases, and statutory regulatory filings.

📢 Disclaimer & Source

Source: This content has been structured and newly written based on officially disclosed financial facts and data from brokerage reports.

Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific securities. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: Compliance and Copyright Inquiries (ksb220805@gmail.com)

Search by
Company Name or Stock Ticker.
Research, EV & Battery

Post navigation

Previous Post: [Research] Samsung SDI (006400) – Kyobo Securities | AI Data Center BBU · Direct CSP Channels · 1Q Earnings Beat / 2026-04-29
Next Post: [Research] Samsung SDI (006400) – DS Investment & Securities | 4Q Turnaround Visibility · Non-PFE LFP ESS · European Volume Models / 2026-04-29

Related Posts

  • [Research] Samsung Biologics (207940) – Mirae Asset | Plant 5 Ramp-up · CDMO Expansion · Earnings Forecast / 2026-07-27 Research
  • [Research] Samsung SDI (006400) – Kyobo Securities | AI Data Center BBU · Direct CSP Channels · 1Q Earnings Beat / 2026-04-29 Research
  • [Research] SK hynix (000660 / SKHY) – iM Securities | Fixed Memory Pricing · Supply Shortage · Earnings Growth / 2026-01-30 Research
  • [Research] SK hynix (000660 / SKHY) – Daishin | Memory ASP · Earnings Upgrades · Valuation Appeal / 2026-03-16 Research
  • [Research] Celltrion (068270) – Shinhan Securities | North American New Product Penetration · 2030 Pipeline · New Drug Cycle / 2026-07-28 Research
  • [Research] LigaChem Biosciences (141080) – iM Securities | Clinical Data · Pipeline Progress · Tech Transfer / 2026-05-21 Research
  • [Research] Samsung SDI (006400) – iM Securities | Surging AIDC ESS Demand · US Regulatory Tailwinds · Valuation Assessment / 2026-04-29 Research
  • [Research] SK hynix (000660 / SKHY) – Shinhan | DRAM Supply Shortage · Supplier Pricing Power · HBM3E / 2026-01-05 Research
  • [Research] Samsung Biologics (207940) – Hana Securities | Post-Spinoff Profitability · Record KRW 6.8T Orders · Plant 6 Groundbreaking Visibility / 2026-01-07 Research
  • [Research] Samsung Biologics (207940) – Hana Securities | Rockville Acquisition Finalized · Guidance Revision Outlook · Tariff Resilience / 2026-04-02 Research
  • [Research] ABL Bio (298380) – DS Investment & Securities | ABL001 Data Readout · ABL111 Phase 3 · Grabody B Expansion / 2026-04-07 Research
  • [Research] Hanwha Ocean (042660) – SK Securities | Merchant Margin Surprise · Cost & Incentive Factors · Earnings Volatility / 2026-07-28 Research
  • [Research] Samsung SDI (006400) – Hana Securities | Plant Utilization Recovery · North America ESS Demand · Valuation Re-rating / 2026-04-29 Research
  • [Research] LIG D&A (079550) – Eugene Investment & Securities | Global Demand Spillover · CapEx Expansion · Long-term Compounding / 2026-08-07 Research

Copyright © 2026 Korea Equity Lens.

Powered by PressBook News Dark theme